Market Tracker

06/23 5:16pm ET

Puma Biotechnology Inc (NASDAQ:PBYI)

87.50
Delayed Data
As of 3:59pm ET
 +1.05 / +1.21%
Today’s Change
27.64
Today|||52-Week Range
92.00
+185.02%
Year-to-Date
Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys
Jun 21 / Zacks.com - Paid Partner Content
3 Biotech Stocks That More than Doubled Year to Date
Jun 19 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Puma (PBYI) Stock Surges as Neratinib Nears FDA Approval
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.45
Today’s open85.50
Day’s range84.35 - 87.85
Volume1,124,649
Average volume (3 months)1,523,804
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-11.28%
Earnings growth (this year)+5.57%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.17

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.71-0.84%
ICPTIntercept Pharmaceut...+1.72+1.32%
CBPOChina Biologic Produ...-0.73-0.65%
IRWDIronwood Pharmaceuti...-0.03-0.15%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$1.91
Annual revenue (last year)$0.00
Annual profit (last year)-$276.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts